Advanced Drug Delivery CDMO Market Size is predicted to show a 4.91% CAGR during the forecast period for 2023-2031.
Key Industry Insights & Findings from the Report:
- Modern medication delivery systems have arisen as a quick and precise way to get the drug to the right place. Technological advancements in medical devices are a significant factor in the market growth.
- CDMOs are increasing their capacity for biopharmaceutical development and production in response to the growing market demand for biosimilars and biologics.
- North America dominated the market and accounted for a global revenue share in 2023.
- Advanced delivery systems are to target drugs to specific tissues or cells; achieving this targeting efficiently and selectively can be challenging.
The pharmaceutical sector greatly benefits from a Contract Development and Manufacturing Organisation (CDMO) specialising in cutting-edge drug delivery technologies. These CDMOs offer services for creating, formulating, and developing drug delivery systems beyond conventional oral tablets or capsules. Modern medication delivery systems have arisen as a quick and precise way to get the drug to the right place. These systems have many advantages over conventional systems, including the focused and regulated delivery of novel molecules to target areas, the consistency of drug absorption, the elimination of frequent dosing, the decrease of hazardous metabolites, and reduced variability in systemic drug concentrations. The need for advanced drug delivery CDMOs has increased as a result of improved drug performance and superior results brought about by advanced drug delivery systems.
However, the Advanced Drug Delivery Contract Development and Manufacturing Organisation (CDMO) market was significantly impacted by the COVID-19 pandemic, which had a wide-ranging effect on the sector. The pandemic affected the availability of raw materials and parts needed for medicine delivery systems by upsetting global supply chains. For several CDMOs, this resulted in manufacturing difficulties and delivery delays.
Competitive Landscape
Some Major Key Players In The Advanced Drug Delivery CDMO Market:
- Evonik Health Care
- SHL Medical
- Lubrizol Life Science
- Acino International AG
- Pharmathen
- Phillips-Medisize (A Molex Company)
- Others
Market Segmentation:
The Advanced Drug Delivery CDMO Market is segmented on the basis of services which is segmented as Analytical Services, Assembly, Labelling and Packaging, and Others.
The Segment, Analytical Services, Accounted As A Major Contributor In The Advanced Drug Delivery CDMO Market.
The analytical services category is expected to hold a major share in the global Advanced Drug Delivery CDMO Market in 2022. The Advanced Drug Delivery Contract Development and Manufacturing Organisation (CDMO) industry heavily relies on analytical services. These services cover a range of analytical and testing procedures used to assess the effectiveness, reliability, and performance of drug delivery systems. Nanoparticles, liposomes, and biodegradable microspheres are just a few of the complex formulations that are frequently used in the creation of sophisticated drug delivery systems. In order to characterize and validate these complex compositions, analytical services are crucial.
In The Region, The North American Advanced Drug Delivery CDMO Market Holds A Significant Revenue Share.
The North America Advanced Drug Delivery CDMO Market is expected to record the maximum market share in terms of revenue in the near future. The region's long-standing CDMO presence distinguishes the market in North America. The region is heavily invested in researching and developing biological medications, gene treatments, and other specialized pharmaceuticals. These complex compounds frequently necessitate specialized drug delivery devices, which drives demand for CDMO services.
Along with this element, expanding partnerships between pharmaceutical firms and CDMOs providing a wide range of services are to blame for the region's leading market share globally. Due to the region's highly qualified workforce and low manufacturing and R&D costs, the Asia Pacific market is estimated to grow significantly over the course of the forecast period.
Recent Developments:
-
In October 2023 – Phillips-Medisize partnered with GlucoModicum, a forward-thinking Finnish medtech startup, to create and eventually market a wearable, non-invasive wearable device that eliminates patient care and technological barriers to continuous glucose monitoring (CGM).
- In March 2023, Evonik has solidified its prominent position in drug delivery for RNA treatments by initiating the construction process for a new pharmaceutical lipids plant in the United States. The newly established facility was anticipated to ensure the industry's uninterrupted availability of essential excipients required for mRNA vaccines and other nucleic acid therapeutics. The commencement of plant operations was planned for the year 2025.
Advanced Drug Delivery CDMO Market Report Scope
Report Attribute |
Specifications |
Growth Rate CAGR |
CAGR of 4.91% from 2023 to 2031 |
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
Historic Year |
2019 to 2022 |
Forecast Year |
2023-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Services |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
Evonik Health Care, SHL Medical, Lubrizol Life Science, Acino International AG, Pharmathen, Phillips-Medisize (A Molex Company), and others. |
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |